MindBio Therapeutics Corp. (CSE:MBIO)
Canada
· Delayed Price · Currency is CAD 0.980
-0.010 (-1.01%)
At close: Apr 28, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 7.14 million as of April 28, 2026. Its market cap has increased by 149.63% in one year.
Market Cap
7.14M
Enterprise Value
8.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 7.14M, a decrease of -91.06%. That is a compound annual growth rate of -55.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 7.21M | 20.32% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 6.36M |
| Aptose Biosciences | 6.00M |
| Quest PharmaTech | 5.92M |
| COSCIENS Biopharma | 8.60M |
| Glow Lifetech | 8.65M |
| PharmaTher Holdings | 9.10M |
| MYND Life Sciences | 5.22M |
| Restart Life Sciences | 5.05M |